Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cleanroom Services Partnership Brings Synergy for Customers

Published: Thursday, May 01, 2014
Last Updated: Thursday, May 01, 2014
Bookmark and Share
Two award-winning laboratory service providers have joined forces to create greater synergy for customers.

Two award-winning laboratory service providers have joined forces to create greater synergy for customers. 


Cleanroom manufacturer Connect2Cleanrooms and specialist laboratory relocation provider Andrew Porter Limited have formed a partnership agreement, which is set to complement and enhance each firm’s service provision. 

Connect2Cleanrooms already provides disassembly, relocation and revalidation of its modular cleanrooms, but the new partnership with Andrew Porter Limited will enable it to offer a full relocation service to include all contents of the cleanroom, such as instrumentation and cold chain materials. 

Relocation of other laboratory spaces outside the cleanroom environment can also be provided, offering customers a turnkey solution. 

Andrew Porter Limited will be able to benefit customers through the partnership by providing modular cleanroom facilities, that could be used temporarily or part of a longer term proposition, for phased moves or where a decant into temporary premises is required as part of a larger relocation. 

This service will further enhance the range of additional services already provided by the company, with Connect2Cleanrooms also assisting Andrew Porter Limited in the training of its operatives to ISO14644-1:1999 EU GGMP, and US Federal standards 209E, where appropriate. 

European sales director at Andrew Porter Limited, John Best, commented: “We have a lot in common with Connect2Cleanrooms. We are both experts in our respective fields and are global companies which are headquartered in Lancashire, UK, so I am really pleased that we will be working together moving forward. 

“The technical specialism we are able to offer to each other’s customers makes this a mutually beneficial partnership that enhances both firms’ service offerings.” 

Joe Govier, managing director of Connect2Cleanrooms, said: “We first met with Andrew Porter Limited when we were both winners at this year’s Red Rose Awards. It is fantastic that the winning did not stop there for either of us and that this partnership will benefit both firms and our customer base now and into the future.” 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!